The GEPIA study reveals that, when compared with normal tissues, the expression of DNMT1 is elevated in CHOL, DLBC, head and neck squamous cell carcinoma (HNSC), pancreatic adenocarcinoma (PAAD), sarcoma (SARC), and thymoma (THYM). This evidence concerns the gene DNMT1 and pancreatic adenocarcinoma.